Dynavax Technologies Corp. (DELISTED) (DVAX:DL)
15.50
0.00 (0.00%)
USD |
NASDAQ |
Feb 19, 16:00
Dynavax Technologies Free Cash Flow : 80.54M for Sept. 30, 2025
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Merck & Co., Inc. | 12.36B |
| Amicus Therapeutics, Inc. | 29.85M |
| Agios Pharmaceuticals, Inc. | -377.29M |
| Hyperion DeFi, Inc. | -16.82M |
| Edgewise Therapeutics, Inc. | -144.07M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | 33.83M |
| Cash from Investing (Quarterly) | 27.32M |
| Cash from Financing (Quarterly) | -0.061M |
| Free Cash Flow Per Share (Quarterly) | 0.2388 |
| Free Cash Flow to Equity (Quarterly) | 32.93M |
| Free Cash Flow to Firm (Quarterly) | 34.15M |
| Free Cash Flow Yield | 3.76% |